logo
Plus   Neg
Share
Email

Sherwin-Williams Boosts Q2 Sales Outlook - Quick Facts

Paint and coating manufacturer Sherwin-Williams Co. (SHW) on Monday raised its consolidated net sales guidance for the second quarter.

For the second quarter, the company now expects 2020 consolidated net sales to decrease by a mid-single-digit percentage, up from the prior forecast for a decline in the low to mid-teens percentage from last year.

On a segment basis, second quarter net sales in The Americas Group are expected to be down by a high-single-digit percentage compared to the previous guidance of down by a low-double-digit to mid-teens percentage.

Net sales in the Consumer Brands Group are expected to be significantly above the high end of the previous guidance of up by a high-single-digit to low-double-digit percentage.

Net sales in the Performance Coatings Group are expected to be in line with the previous guidance of down by a high-teens percentage.

The Company said it is scheduled to release second quarter 2020 financial results on July 28, 2020, and will provide its outlook on third quarter sales and update its full year sales and earnings per share guidance at that time.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Humana Inc. (HUM) reported second quarter adjusted earnings per share of $12.56 compared to $6.05, previous year. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $10.27, for the quarter. Analysts' estimates typically exclude special items. Second... H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products. The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter.
Follow RTT